Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
527.44
-7.56 (-1.41%)
At close: Jan 20, 2026, 4:00 PM EST
529.00
+1.56 (0.30%)
After-hours: Jan 20, 2026, 7:59 PM EST
Intuitive Surgical Stock Forecast
Stock Price Forecast
The 14 analysts that cover Intuitive Surgical stock have a consensus rating of "Buy" and an average price target of $609.29, which forecasts a 15.52% increase in the stock price over the next year. The lowest target is $440 and the highest is $740.
Price Target: $609.29 (+15.52%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Intuitive Surgical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 2 | 2 |
| Buy | 8 | 8 | 8 | 8 | 7 | 8 |
| Hold | 2 | 2 | 2 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 16 | 16 | 16 | 16 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Maintains $700 → $740 | Buy | Maintains | $700 → $740 | +40.30% | Jan 9, 2026 |
| Barclays | Barclays | Buy Maintains $635 → $686 | Buy | Maintains | $635 → $686 | +30.06% | Jan 7, 2026 |
| BTIG | BTIG | Strong Buy Maintains $589 → $616 | Strong Buy | Maintains | $589 → $616 | +16.79% | Jan 7, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $620 → $650 | Strong Buy | Maintains | $620 → $650 | +23.24% | Dec 18, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $625 → $650 | Buy | Maintains | $625 → $650 | +23.24% | Dec 17, 2025 |
Financial Forecast
Revenue This Year
10.12B
from 8.35B
Increased by 21.14%
Revenue Next Year
11.64B
from 10.12B
Increased by 15.00%
EPS This Year
8.81
from 6.42
Increased by 37.15%
EPS Next Year
9.92
from 8.81
Increased by 12.70%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.6B | 13.0B | ||||
| Avg | 10.1B | 11.6B | ||||
| Low | 9.6B | 10.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 26.8% | 28.7% | ||||
| Avg | 21.1% | 15.0% | ||||
| Low | 14.5% | 7.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.19 | 11.79 | ||||
| Avg | 8.81 | 9.92 | ||||
| Low | 8.18 | 8.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 43.1% | 33.9% | ||||
| Avg | 37.1% | 12.7% | ||||
| Low | 27.5% | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.